NewsBenzingaImmunocore presentará datos del ensayo de fase 1/2 que evalúan brenetafusp solo y en combinación con KIMMTRAK en pacientes HLA-A*02:01 positivos con melanoma uveal metastásico, en la Reunión Anual 2026 de la SITC Immunocore presentará datos del ensayo de fase 1/2 que evalúan brenetafusp solo y en combinación con KIMMTRAK en pacientes HLA-A*02:01 positivos con melanoma uveal metastásico, en la Reunión Anual 2026 de la SITC Benzinga 2026.10.29 13:04 (GMT+0) Open on Benzinga Other news Ramp in Talks to Raise at Least $1 Billion at Valuation of Up to $75 Billion How Everyday Investors Are Playing the Nvidia Drama Curve: Fee Conversion Contract Loses $38.2K in Attack, Disabled With Replacement Planned Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares